Home About Products & Services News Research Investors Contact


The Neuronetics management team brings substantial life science experience with an emphasis on psychiatric and neurological products. Take a moment to get to know the management team that continues to make Neuronetics an innovator in treating patients with major depression:

Bruce J. Shook, President and CEO

Mark R. Bausinger, Chief Financial Officer

Mark A. Demitrack, M.D., Chief Medical Officer

Mary Hailey, VP of Health Policy and Government Relations

Suzanne McMonigle, VP Marketing

Stanford W. Miller, VP Business Development

Mark E. Riehl, VP Product Development and Operations

Mark Saxton, VP Sales

Judy P. Ways, Ph.D., VP Regulatory Affairs and Quality Assurance

Find a NeuroStar TMS Therapy Provider Near You

If you or a loved one is suffering from major depression, you can find a NeuroStar TMS Therapy provider in your area.

Provide NeuroStar TMS Therapy in Your Practice

Provide your patients the new way back with NeuroStar TMS Therapy®. Contact us to find out how you can begin providing therapy.

This link provides you with access to recent published information and news about NeuroStar TMS Therapy and new options for the treatment of depression. Neuronetics does not provide any assurances of the accuracy of this information and may not agree with the opinions of the authors.

NeuroStar TMS Therapy is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode. To return to the Neuronetics website for full safety and prescribing information click here.

Click here to continue.